In a study, anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibodies were significantly more frequent among patients with progressive fibrosing ILD (PF-ILD) compared to those without disease progression (29% vs. 6%, p = 0.03). The gene discussed is IFIH1; the disease is pemphigus foliaceus.